Skip to main content

and
  1. No Access

    Chapter and Conference Paper

    Multicenter Clinical Trial up to 15 Months: Efficacy and Tolerability of Acarbose in Glibenclamide-Treated Type II Diabetics with Secondary Sulfonylurea Failure Versus Glibenclamide Therapy Alone

    The principle of delaying the enteral digestion of carbohydrates by inhibiting intestinal glucosidases is a successful new therapeutic approach for the treatment of diabetes mellitus. When used either as a mon...

    M. Spengler, K. Boehme, R. Aubell in Acarbose for the Treatment of Diabetes Mellitus (1988)